Results

Total Results: 944 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/mx2Ko29RH46mTYb36f-UBe
    June 20, 2023 - events, even if they have proven benefits. … events. … Evidence demonstrated an increase in nonserious harms (defined as any adverse events and withdrawals … due to adverse events). … Serious adverse events were rare and data were insufficient to determine whether pharmacotherapy increased
  2. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary13/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-behavioral-counseling
    December 07, 2010 - Key Question 4: Harms Adverse effects were rarely noted in physical activity counseling trials. … We found no studies designed to assess the adverse effects of dietary counseling or the adverse effects … None of the healthful diet counseling trials reported specific adverse events. … However, the absolute risk for serious cardiac events related to physical activity seems very small. … events not reported in trials Good Good No specific examination of adverse effects; however, 2
  3. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults
    December 15, 2010 - Key Question 4: Harms Adverse effects were rarely noted in physical activity counseling trials. … We found no studies designed to assess the adverse effects of dietary counseling or the adverse effects … None of the healthful diet counseling trials reported specific adverse events.   … However, the absolute risk for serious cardiac events related to physical activity seems very small. … events not reported in trials Good Good No specific examination of adverse effects
  4. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary13/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-behavioral-counseling-2012
    December 07, 2010 - Key Question 4: Harms Adverse effects were rarely noted in physical activity counseling trials. … We found no studies designed to assess the adverse effects of dietary counseling or the adverse effects … None of the healthful diet counseling trials reported specific adverse events. … However, the absolute risk for serious cardiac events related to physical activity seems very small. … events not reported in trials Good Good No specific examination of adverse effects; however, 2
  5. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
    December 15, 2010 - Key Question 4: Harms Adverse effects were rarely noted in physical activity counseling trials. … We found no studies designed to assess the adverse effects of dietary counseling or the adverse effects … None of the healthful diet counseling trials reported specific adverse events.   … However, the absolute risk for serious cardiac events related to physical activity seems very small. … events not reported in trials Good Good No specific examination of adverse effects
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-deficiency-screening-november-2014
    November 24, 2014 - events, hypercalcemia, kidney stones, or gastrointestinal symptoms. … However, it is unclear if low 25-(OH)D levels are associated with adverse clinical outcomes in these … The USPSTF identified 24 studies 1 , 2 that reported on the adverse effects of vitamin D treatment; … however, most trials were not designed to assess harms, and reporting of adverse events was generally … No significant difference in rates of serious adverse events or withdrawals due to adverse events was
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening
    March 01, 2016 - use vs placebo in risk of any adverse events (93% vs 89%; RR, 1.05; 95% CI, 0.97–1.13), serious adverseevents (31% vs 30%; RR, 1.04; 95% CI, 0.72–1.49), or serious ocular adverse events (8.2% vs 7.0%; RR … events, but estimates for those outcomes were imprecise. … events in participants taking zinc vs placebo. … No increase in risk of systemic hypertension or arterial thromboembolic events.
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
    March 01, 2016 - use vs placebo in risk of any adverse events (93% vs 89%; RR, 1.05; 95% CI, 0.97–1.13), serious adverseevents (31% vs 30%; RR, 1.04; 95% CI, 0.72–1.49), or serious ocular adverse events (8.2% vs 7.0%; RR … events, but estimates for those outcomes were imprecise. … events in participants taking zinc vs placebo. … No increase in risk of systemic hypertension or arterial thromboembolic events.
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
    June 11, 2019 - Limited data suggest that PrEP use is not associated with significant adverse events in adolescents but … There was no clear difference in risk of kidney adverse events when trials were stratified according … of serious renal events or with- drawals due to renal events.31,32 Six trials41,42,55-58 evaluated whether … renal adverse events while using PrEP were persistent. … The risk of gastrointes- tinal adverse events increased with both tenofovir disoproxil fuma- rate monotherapy
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/mfyVxbhXeqBjMR6jLJcLr4
    May 24, 2022 - or other serious adverse events, although no statistically significant differences were reported.24,27,44,66 … events and cardiovascular events were infre- quent and occurred in similar proportions of patients randomized … VECAT (n = 1193), the largest trial other than AREDS and AREDS2, reported no serious adverse events with … vitamin E or pla- cebo, and no differences in risk of withdrawal due to adverse events or specific adverse … but did not indicate increased risk of serious adverse events or withdrawal due to adverse events.
  11. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary39/obesity-in-children-and-adolescents-screening-2010
    January 15, 2010 - , any serious adverse event, or discontinuation caused by adverse events. … In the large 12-month sibutramine trial, serious adverse events were reported by 2.7% of patients in … Weight-management programs for which pre-specified adverse events that resulted in death, hospitalization … No minimum follow-up is required for serious (ie, requiring urgent medical care) adverse events (KQ3) … For trials that were not included for KQ1 or KQ2, outcomes were limited to serious adverse events such
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
    October 01, 2011 - events Context Experts recommend that primary care clinicians offer obese adults interventions that … events (Table 2) (22, 83, 102). … No studies re- ported serious adverse effects. … Summary of Medication Harms Adverse Events Trials in Meta-analysis, Additional Trials, n, n Meta-analysis … Meridia (sibutramine): market with- drawal due to risk for serious cardiovascular events.
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/VKGPkVjto7K4yfUHBKEHBA
    January 01, 2025 - of findings from the Women’s Health Initiative that hormone therapy use is associated with serious adverse … findings from the Women’s Health Initiative (WHI) that hormone therapy use was associated with serious adverse … individual char- acteristics that affect the likelihood of experiencing a specific therapy- associated adverse … in women at increased risk of breast cancer who do not have contraindications and are at low risk of adverse … individual characteristics that affect the likelihood of experiencing a specific therapy-associated adverse
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/RPB3rmcS9CK_eXPdzXSxZg
    July 01, 2010 - Bisphosphonates are not con­ sistently associated with serious adverse events; raloxifene and es­ trogen … increase thromboembolic events; and estrogen causes addi­ tional adverse events. … no differences with placebo in rates of serious gastrointestinal adverse events (107, 108) or withdrawals … Upper gastrointestinal adverse events and cyclical etidronate. Am J Med. 1997;103:462-7. … Adverse Health Outcomes from Studies, by Medication Adverse Outcome Evidence Bisphosphonates Withdrawals
  15. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/genital-herpes-serologic-screening
    July 08, 2021 - KQ 4: Reduced rates (or frequency) of subclinical HSV-2 viral shedding KQ 6: Treatment-related adverseevents (e.g., adverse drug reactions related to antiviral medications); psychosocial harms related to
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/VwvmgA5bLZZJhK6YSqRonU
    November 01, 2022 - Adverse health outcomes associated with untreated OSA include cardiovascular disease and cerebrovascular … events, type 2 diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/4zmYnqJXLv8g4LzLrrDDrm
    December 01, 2014 - effectiveness of low-dose aspirin in preventing preeclampsia in women at in- creased risk and in decreasing adverseevents. … Assessment of Risk for Adverse Effects Low-dose aspirin use in women at increased risk for preeclampsia … Eighteen trials reported on the outcome of perinatal mortality (with 4 smaller studies reporting no events … Seven trials reported adverse events; however, most were determined to be unrelated to treatment.
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-pad-screening
    August 08, 2005 - group; however, the study did not address the impact of interventions on PAD or cardiovascular disease events … intermittent claudication. 14 Potential harms of screening include false-positive results, labeling, and the adverseevents associated with an angiographic workup, including contrast-related events, arterial perforations … , hematomas, thromboses, and distal embolizations; the harms of treatment include the adverse events
  19. www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-pad-screening-2005
    August 08, 2005 - group; however, the study did not address the impact of interventions on PAD or cardiovascular disease events … intermittent claudication. 14 Potential harms of screening include false-positive results, labeling, and the adverseevents associated with an angiographic workup, including contrast-related events, arterial perforations … , hematomas, thromboses, and distal embolizations; the harms of treatment include the adverse events
  20. www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening
    June 15, 2008 - USPSTF reviewed the evidence on early treatment of type 2 diabetes mellitus in preventing long-term adverse … Potential Harms of Screening and Treatment: Observational studies report no serious long-term adverse … No studies reported adverse effects of receiving a diagnosis of IFG or IGT, and no studies examined the … agents. 15 Angiotensin-converting enzyme inhibitors and statins have reasonably low levels of serious adverse … The relationship between glucose and incident cardiovascular events.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: